MegaBLAST

MegaBLAST
Name	MegaBLAST
Developer	National Center for Biotechnology Information
Initial release	1990s
License	Public domain / NCBI policies
Website	NCBI BLAST

MegaBLAST

MegaBLAST is a high-throughput nucleotide sequence alignment program developed for rapid searching of large nucleotide databases; it optimizes for speed over sensitivity and is widely used in genomics, metagenomics, and clinical bioinformatics. Designed as a variant of the BLAST suite, it has been integrated into workflows at institutions such as the National Institutes of Health, Broad Institute, European Bioinformatics Institute, Cold Spring Harbor Laboratory, and industry labs including Illumina and Thermo Fisher Scientific. MegaBLAST underpins pipelines that connect resources like GenBank, RefSeq, UniProt, Ensembl, and large-scale projects such as the Human Genome Project, 1000 Genomes Project, Earth Microbiome Project, and Human Microbiome Project.

Overview

MegaBLAST functions as a nucleotide-to-nucleotide search engine tailored for aligning long, highly similar sequences drawn from repositories like GenBank and RefSeq. Its design emphasizes throughput for applications in comparative genomics at centers including Broad Institute, Wellcome Sanger Institute, J. Craig Venter Institute, Max Planck Society, and Lawrence Berkeley National Laboratory. MegaBLAST is commonly deployed alongside tools such as BLAST+, BLAT, BWA, Bowtie, LASTZ, and Minimap2 in analyses performed by researchers at Stanford University, Harvard University, Massachusetts Institute of Technology, University of California, Berkeley, and University of Cambridge.

Algorithm and Implementation

MegaBLAST adapts the original algorithms from the BLAST family developed by teams at National Center for Biotechnology Information and collaborators such as Stephen Altschul and David Lipman. It uses a greedy, seed-and-extend approach with large word sizes and an indexed lookup table similar to techniques used in suffix arrays and hash tables implemented in projects at Los Alamos National Laboratory and Sandia National Laboratories. Implementations in C are optimized for multi-threading on architectures by Intel Corporation and Advanced Micro Devices and integrated in compute environments like XSEDE, Amazon Web Services, Google Cloud Platform, and Microsoft Azure. MegaBLAST’s heuristics trade sensitivity for speed similar to algorithmic choices in BLAST, FASTA, and Smith–Waterman algorithm derivatives.

Applications and Use Cases

MegaBLAST is used for rapid identification of near-identical sequences in contexts such as genome assembly validation at Broad Institute, contamination screening in sequencing centers like Wellcome Sanger Institute, taxonomic assignment in projects like Earth Microbiome Project, and clinical pathogen detection in institutions such as Centers for Disease Control and Prevention and Mayo Clinic. It supports workflows in metagenomics analyses by teams at California Institute of Technology, University of Oxford, Karolinska Institutet, Max Delbrück Center for Molecular Medicine, and biotechnology companies including Ginkgo Bioworks and 10x Genomics. MegaBLAST is used in annotation pipelines feeding resources such as RefSeq, GenBank, Ensembl, and databases curated by UniProt and DDBJ.

Performance and Comparisons

MegaBLAST offers high speed for long, closely related nucleotide matches, often preferred over sensitive aligners used by European Molecular Biology Laboratory researchers when aligning assemblies from projects like Human Genome Project and 1000 Genomes Project. Comparative benchmarks versus BLASTN, BLAST+, BWA-MEM, Bowtie2, and Minimap2 have been reported by groups at European Bioinformatics Institute, Wellcome Sanger Institute, and Broad Institute showing MegaBLAST’s faster runtime and lower memory footprint on certain datasets. Performance trade-offs mirror discussions in literature from Nature, Science, Genome Research, and conference proceedings of ISMB and RECOMB, where algorithmic trade-offs between sensitivity and throughput are central.

Limitations and Biases

MegaBLAST’s principal limitation is reduced sensitivity for divergent sequences, making it less suitable for detecting remote homology in studies by teams at University of California, San Francisco, Yale University, Princeton University, and Cold Spring Harbor Laboratory compared with tools like DIAMOND or alignment algorithms rooted in the Smith–Waterman algorithm. Its reliance on large word sizes can bias results against short reads produced by platforms such as Illumina’s earlier instruments, Oxford Nanopore Technologies, and Pacific Biosciences long-read technologies when error profiles differ; these biases have been documented by sequencing centers including Wellcome Sanger Institute and Broad Institute. In clinical settings governed by organizations like Food and Drug Administration and European Medicines Agency, these limitations necessitate complementary validation with more sensitive methods.

History and Development

MegaBLAST emerged in the evolution of BLAST tools at the National Center for Biotechnology Information building on the foundational work of researchers including Stephen Altschul, David Lipman, Warren Gish, and teams collaborating across NIH and academic centers. Its development paralleled major genomics milestones such as the Human Genome Project and subsequent large-scale initiatives like 1000 Genomes Project and Human Microbiome Project, driven by demands from sequencing centers at Broad Institute, Wellcome Sanger Institute, J. Craig Venter Institute, and corporate sequencing efforts by Illumina and Thermo Fisher Scientific. Ongoing maintenance and integration with resources like NCBI Entrez and BLAST+ ensure MegaBLAST remains part of standard bioinformatics toolkits used in academia, government labs, and industry.

Category:Bioinformatics software